BFRI 1 (-3.85%)
US09077D1000Drug ManufacturersDrug Manufacturers - Specialty & Generic

Biofrontera (BFRI) Competitor Comparison

We are evaluating the key criteria listed to compare Biofrontera (BFRI) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 10 years - BFRI ranking 44 / 54

These are the competitors of Biofrontera in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 10 years
1. Theratechnologies THTX
76.22
2. PetIQ PETQ
20.03
3. Alimera Sciences ALIM
19.74
4. Phibro Animal Health PAHC
18.73
5. Evolus EOLS
16.88
6. Eagle Pharmaceuticals EGRX
12.84
7. Green Thumb Industries R9U2.F
9.09
8. Regencell Bioscience Holdings RGC
8.64
9. Vifor Pharma G2AB.F
7.23
10. Linc LNC
6.93
11. Emergent BioSolutions EBS
6.06
12. Ironwood Pharmaceuticals IRWD
4.95
13. Kolinpharma KIP.MI
4.84
14. Curaleaf Holdings CURLF
4.8
15. Ayr Wellness 3KJB.F
4.78
16. Avadel Pharmaceuticals AVDL
4.52
17. Kamada KMDA
4.39
18. Alvotech ALVO
3.98
19. Elanco Animal Health ELAN
3.91
20. Cumberland Pharmaceuticals CPIX
3.87
21. Societal CDMO SCTL
3.72
22. Taro Pharmaceutical Industries TARO
3.67
23. Organogenesis Holdings ORGO
3.26
24. Procaps Group PROC
3.13
25. Pacira BioSciences PCRX
2.95
26. Cronos Group CRON
2.92
27. Amneal Pharmaceuticals AMRX
2.58
28. Embecta EMBC
2.55
29. Teva Pharmaceutical Industries TEVA
2.44
30. Tilray Brands TLRY
2.44
31. Perrigo PRGO
2.34
32. Neoleukin Therapeutics NLTX
2.29
33. Catalent CTLT
2.26
34. Journey Medical DERM
2.17
35. Supernus Pharmaceuticals SUPN
2.16
36. ANI Pharmaceuticals ANIP
2.13
37. Clever Leaves Holdings CLVR
1.84
38. Jupiter Wellness JUPW
1.84
39. Flora Growth FLGC
1.76
40. Ascend Wellness Holdings AAWH
1.76
41. Alpha Teknova TKNO
1.73
42. OptiNose OPTN
1.72
43. Bausch Health Companies BHC
1.71
44. Biofrontera BFRI
1.69
45. Universe Pharmaceuticals UPC
1.68
46. Relmada Therapeutics RLMD
1.66
47. Solid Biosciences SLDB
1.66
48. Zynerba Pharmaceuticals ZYNE
1.63
49. SCYNEXIS SCYX
1.58
50. ProPhase Labs PRPH
1.46
51. Collegium Pharmaceutical COLL
0.92
52. Zoetis ZTS
0.64
53. Amphastar Pharmaceuticals AMPH
0.49
54. Harrow Health HROW
0.46

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.